WordNet

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2016/03/15 21:25:48」(JST)

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 急性移植片対宿主病の臨床症状、診断、および重症度分類 clinical manifestations diagnosis and grading of acute graft versus host disease
2. 移植片対宿主病の予防および治療に使用される免疫抑制剤の概要 overview of immunosuppressive agents used for prevention and treatment of graft versus host disease
3. 急性移植片対宿主病の治療 treatment of acute graft versus host disease
4. 慢性移植片対宿主病の臨床症状、診断、および重症度分類 clinical manifestations diagnosis and grading of chronic graft versus host disease
5. 慢性移植片対宿主病の治療 treatment of chronic graft versus host disease

Levy MJ, Wong Kee Song LM.SourceDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Gastrointestinal endoscopy.Gastrointest Endosc.2013 Nov;78(5):722-725. doi: 10.1016/j.gie.2013.07.004.
PMID 24120335

Cytokine Induced Killer (CIK) cells for the treatment of haematological neoplasms.

Introna M, Golay J, Rambaldi A.SourceLaboratorio di Terapia Cellulare "G. Lanzani", USC Ematologia, Ospedale Papa Giovanni XXIII, Bergamo, Italy. Electronic address: mintrona@hpg23.it.
Immunology letters.Immunol Lett.2013 Sep 29. pii: S0165-2478(13)00140-5. doi: 10.1016/j.imlet.2013.09.017. [Epub ahead of print]
Cytokine Induced Killer (CIK) cells are in vitro activated human CD8 T cells which have maintained several characteristics of T-EMRA cells and additionally acquired non specific anti tumoral cytotoxicity and CD56 overexpression, thus representing a cell population with double T and NK phenotype. Due
PMID 24084446

In vivo activation of transferred regulatory T cells specific for third-party exogenous antigen controls GVH disease in mice.

Martin GH, Grégoire S, Landau DA, Pilon C, Grinberg-Bleyer Y, Charlotte F, Mège JP, Chatenoud L, Salomon BL, Cohen JL.SourceUPMC Univ Paris 06, CNRS UMR7211, INSERM U959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France.
European journal of immunology.Eur J Immunol.2013 Sep;43(9):2263-72. doi: 10.1002/eji.201343449. Epub 2013 Jul 9.
Treg cells hold enormous promise for therapeutic application in GVH disease, a lethal complication of allogeneic HSC transplantation. Mouse studies showed that donor-derived recipient-specific Treg (rsTreg) cells are far more efficient than polyclonal Treg cells in suppressing GVH disease. However,
PMID 23765389

池亀和博,小川啓恭
臨床血液 56(3), 289-297, 2015
血縁HLA半合致ドナーからの移植（ハプロ移植）は，代替ドナーからの移植として注目されつつある。特にpost-transplant cyclophosphamide (PTCY)が出てからは，欧米はもとより日本でも広まりつつある。このような海外のハプロ移植の状況を踏まえ，本邦の現状と我々の取り組みを紹介する。当初開発したhaplo-full (original)は治療関連毒性が問題であり，ATGを加 …
NAID 130005065336

田中淳司
東京女子医科大学雑誌 84(3), 87-93, 2014-04-25
… またKIR (Killer Ig-like receptor)リガンドのGVH方向不適合によって誘導されるドナー同種反応性NK細胞は患者白血病細胞を攻撃しGVL効果を発揮すると同時に、患者抗原提示細胞 (antigen-presenting cell, APC)を攻撃しGVHDをも抑制すると考えられる。 …
NAID 110009803926